Skip to content
PubMed This is a summary of 83 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 83 referenced papers

Top Authors

Sobha Sivaprasad
Moorfields Eye Hospital NHS Foundation Trust
Francesco Bandello
Vita-Salute San Raffaele University
Usha Chakravarthy
Queen's University Belfast
Stela Vujosevic
University of Milan
Anat Loewenstein
Tel Aviv University
Nadia K. Waheed
Tufts University
Neil M. Bressler
Johns Hopkins University
Carol Y. Cheung
Chinese University of Hong Kong
Rajiv Raman
Sankara Nethralaya
Lloyd Paul Aiello
Joslin Diabetes Center

Top Institutions

Ranked by publications Top 10 institutions
02

Moorfields Eye Hospital NHS Foundation Trust

London, United Kingdom

67 papers

References

References (83)
  1. 1

    Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema.

    , Wells JA, Glassman AR, et al.

    The New England journal of medicine 2015; (372(13)):1193-203 doi:10.1056/NEJMoa1414264.

    PMID: 25692915
  2. 2

    Ageing of the vitreous: From acute onset floaters and flashes to retinal detachment.

    Lumi X, Hawlina M, Glavač D, et al.

    Ageing research reviews 2015; (21()):71-7.

    PMID: 25841656
  3. 3

    Diabetic Macular Edema: Pathophysiology and Novel Therapeutic Targets.

    Das A, McGuire PG, Rangasamy S

    Ophthalmology 2015; (122(7)):1375-94.

    PMID: 25935789
  4. 4

    Angiopoietin-like 4 is a potent angiogenic factor and a novel therapeutic target for patients with proliferative diabetic retinopathy.

    Babapoor-Farrokhran S, Jee K, Puchner B, et al.

    Proceedings of the National Academy of Sciences of the United States of America 2015; (112(23)):E3030-9 doi:10.1073/pnas.1423765112.

    PMID: 26039997
  5. 5

    Comparison of Prevalence of Diabetic Macular Edema Based on Monocular Fundus Photography vs Optical Coherence Tomography.

    Wang YT, Tadarati M, Wolfson Y, et al.

    JAMA ophthalmology 2016; (134(2)):222-8 doi:10.1001/jamaophthalmol.2015.5332.

    PMID: 26719967
  6. 6

    Retinal Imaging Techniques for Diabetic Retinopathy Screening.

    Goh JK, Cheung CY, Sim SS, et al.

    Journal of diabetes science and technology 2016; (10(2)):282-94 doi:10.1177/1932296816629491.

    PMID: 26830491
  7. 7

    Advances in retinal imaging for diabetic retinopathy and diabetic macular edema.

    Tan CS, Chew MC, Lim LW, Sadda SR

    Indian journal of ophthalmology 2016; (64(1)):76-83 doi:10.4103/0301-4738.178145.

    PMID: 26953028
  8. 8

    Diabetic Macular Edema.

    Gundogan FC, Yolcu U, Akay F, et al.

    Pakistan journal of medical sciences 2016; (32(2)):505-10 doi:10.12669/pjms.322.8496.

    PMID: 27182271
  9. 9

    [National guidelines for treatment of diabetic retinopathy : Second edition of the national guidelines for treatment of diabetic retinopathy].

    Ziemssen F, Lemmen K, Bertram B, et al.

    Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 2016; (113(7)):623-38 doi:10.1007/s00347-016-0315-8.

    PMID: 27352282
  10. 10

    Non-Mydriatic Fundus Camera Screening for Referral-Warranted Diabetic Retinopathy in a Northern California Safety-Net Setting.

    Toy BC, Aguinaldo T, Eliason J, Egbert J

    Ophthalmic surgery, lasers & imaging retina 2016; (47(7)):636-42 doi:10.3928/23258160-20160707-05.

    PMID: 27434895
  11. 11

    Optical Coherence Tomography Angiography of Chorioretinal Diseases.

    Novais EA, Roisman L, de Oliveira PR, et al.

    Ophthalmic surgery, lasers & imaging retina 2016; (47(9)):848-61 doi:10.3928/23258160-20160901-09.

    PMID: 27631482
  12. 12

    PARS PLANA VITRECTOMY FOR DIABETIC MACULAR EDEMA: A Systematic Review, Meta-Analysis, and Synthesis of Safety Literature.

    Jackson TL, Nicod E, Angelis A, et al.

    Retina (Philadelphia, Pa.) 2017; (37(5)):886-895 doi:10.1097/IAE.0000000000001280.

    PMID: 27632713
  13. 13

    Anti-Vascular Endothelial Growth Factor Agents in the Treatment of Retinal Disease: From Bench to Bedside.

    Campochiaro PA, Aiello LP, Rosenfeld PJ

    Ophthalmology 2016; (123(10S)):S78-S88 doi:10.1016/j.ophtha.2016.04.056.

    PMID: 27664289
  14. 14

    Clinical Course and Risk Factors of Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus in Korea.

    Yun JS, Lim TS, Cha SA, et al.

    Diabetes & metabolism journal 2016; (40(6)):482-493 doi:10.4093/dmj.2016.40.6.482.

    PMID: 27766793
  15. 15

    Associations between diabetic retinopathy and systemic risk factors.

    Wat N, Wong RL, Wong IY

    Hong Kong medical journal = Xianggang yi xue za zhi 2016; (22(6)):589-99 doi:10.12809/hkmj164869.

    PMID: 27779095
  16. 16

    Optimizing Medical Management in Patients with Sight-Threatening Diabetic Retinopathy.

    Mamtora S, Sandinha T, Carey PE, Steel DHW

    Ophthalmology and therapy 2017; (6(1)):105-114 doi:10.1007/s40123-016-0069-z.

    PMID: 27858333
  17. 17

    Fluocinolone Acetonide Intravitreal Implant 0.19 mg (ILUVIEN®): A Review in Diabetic Macular Edema.

    Syed YY

    Drugs 2017; (77(5)):575-583 doi:10.1007/s40265-017-0722-4.

    PMID: 28283896
  18. 18

    Diabetic retinopathy and OCT angiography: clinical findings and future perspectives.

    de Barros Garcia JMB, Isaac DLC, Avila M

    International journal of retina and vitreous 2017; (3()):14 doi:10.1186/s40942-017-0062-2.

    PMID: 28293432
  19. 19

    Frequency of Evidence-Based Screening for Retinopathy in Type 1 Diabetes.

    , Nathan DM, Bebu I, et al.

    The New England journal of medicine 2017; (376(16)):1507-1516 doi:10.1056/NEJMoa1612836.

    PMID: 28423305
  20. 20

    Guidelines for the Management of Diabetic Macular Edema by the European Society of Retina Specialists (EURETINA).

    Schmidt-Erfurth U, Garcia-Arumi J, Bandello F, et al.

    Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde 2017; (237(4)):185-222 doi:10.1159/000458539.

    PMID: 28423385
  21. 21

    Anti-Vascular Endothelial Growth Factor Injections: The New Standard of Care in Proliferative Diabetic Retinopathy?

    Li X, Zarbin MA, Bhagat N

    Developments in ophthalmology 2017; (60()):131-142 doi:10.1159/000459699.

    PMID: 28427072
  22. 22

    Plastic roles of pericytes in the blood-retinal barrier.

    Park DY, Lee J, Kim J, et al.

    Nature communications 2017; (8()):15296 doi:10.1038/ncomms15296.

    PMID: 28508859
  23. 23

    The United Kingdom Diabetic Retinopathy Electronic Medical Record Users Group: Report 3: Baseline Retinopathy and Clinical Features Predict Progression of Diabetic Retinopathy.

    Lee CS, Lee AY, Baughman D, et al.

    American journal of ophthalmology 2017; (180()):64-71 doi:10.1016/j.ajo.2017.05.020.

    PMID: 28572062
  24. 24

    Fluocinolone acetonide for the treatment of diabetic macular edema.

    Veritti D, Sarao V, Diplotti L, et al.

    Expert opinion on pharmacotherapy 2017; (18(14)):1507-1516 doi:10.1080/14656566.2017.1363182.

    PMID: 28764565
  25. 25

    [OPTICAL COHERENCE TOMOGRAPHY CHARACTERISTICS OF DIABETIC MACULAR OEDEMA].

    Matas A, Ivanišević M

    Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti 2015; (69(5)):481-5.

    PMID: 29087096
  26. 26

    Early worsening of diabetic retinopathy after rapid improvement of blood glucose control in patients with diabetes.

    Feldman-Billard S, Larger É, Massin P,

    Diabetes & metabolism 2018; (44(1)):4-14 doi:10.1016/j.diabet.2017.10.014.

    PMID: 29217386
  27. 27

    Use of OCTA, FA, and Ultra-Widefield Imaging in Quantifying Retinal Ischemia: A Review.

    Or C, Sabrosa AS, Sorour O, et al.

    Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) 2018; (7(1)):46-51 doi:10.22608/APO.201812.

    PMID: 29436208
  28. 28

    Venous beading in two or more quadrants might not be a sensitive grading criterion for severe nonproliferative diabetic retinopathy.

    Chen L, Zhang X, Wen F

    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 2018; (256(6)):1059-1065 doi:10.1007/s00417-018-3971-3.

    PMID: 29626228
  29. 29

    Outcomes of Eyes Lost to Follow-up with Proliferative Diabetic Retinopathy That Received Panretinal Photocoagulation versus Intravitreal Anti-Vascular Endothelial Growth Factor.

    Obeid A, Su D, Patel SN, et al.

    Ophthalmology 2019; (126(3)):407-413 doi:10.1016/j.ophtha.2018.07.027.

    PMID: 30077614
  30. 30

    Rationale and Application of the Protocol S Anti-Vascular Endothelial Growth Factor Algorithm for Proliferative Diabetic Retinopathy.

    Sun JK, Glassman AR, Beaulieu WT, et al.

    Ophthalmology 2019; (126(1)):87-95 doi:10.1016/j.ophtha.2018.08.001.

    PMID: 30096354
  31. 31

    Evidence-based Danish guidelines for screening of diabetic retinopathy.

    Grauslund J, Andersen N, Andresen J, et al.

    Acta ophthalmologica 2018; (96(8)):763-769 doi:10.1111/aos.13936.

    PMID: 30311394
  32. 32

    The unmet need for better risk stratification of non-proliferative diabetic retinopathy.

    Sivaprasad S, Pearce E

    Diabetic medicine : a journal of the British Diabetic Association 2019; (36(4)):424-433 doi:10.1111/dme.13868.

    PMID: 30474144
  33. 33

    Symptoms related to posterior vitreous detachment and the risk of developing retinal tears: a systematic review.

    Gishti O, van den Nieuwenhof R, Verhoekx J, van Overdam K

    Acta ophthalmologica 2019; (97(4)):347-352 doi:10.1111/aos.14012.

    PMID: 30632695
  34. 34

    Risk Factors for Retinopathy in Type 1 Diabetes: The DCCT/EDIC Study.

    Hainsworth DP, Bebu I, Aiello LP, et al.

    Diabetes care 2019; (42(5)):875-882 doi:10.2337/dc18-2308.

    PMID: 30833368
  35. 35

    Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Retinopathy: Consequences of Inadvertent Treatment Interruptions.

    Wubben TJ, Johnson MW,

    American journal of ophthalmology 2019; (204()):13-18 doi:10.1016/j.ajo.2019.03.005.

    PMID: 30878488
  36. 36

    The relationship between diabetic retinopathy and psychosocial functioning: a systematic review.

    Khoo K, Man REK, Rees G, et al.

    Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2019; (28(8)):2017-2039 doi:10.1007/s11136-019-02165-1.

    PMID: 30879245
  37. 37

    Surgical management of diabetic tractional retinal detachments.

    Iyer SSR, Regan KA, Burnham JM, Chen CJ

    Survey of ophthalmology 2019; (64(6)):780-809 doi:10.1016/j.survophthal.2019.04.008.

    PMID: 31077688
  38. 38

    First-line treatment algorithm and guidelines in center-involving diabetic macular edema.

    Kodjikian L, Bellocq D, Bandello F, et al.

    European journal of ophthalmology 2019; (29(6)):573-584 doi:10.1177/1120672119857511.

    PMID: 31238719
  39. 39

    Comparing diabetic retinopathy lesions in scanning laser ophthalmoscopy and colour fundus photography.

    Nghiem AZ, Nderitu P, Lukic M, et al.

    Acta ophthalmologica 2019; (97(8)):e1035-e1040 doi:10.1111/aos.14106.

    PMID: 31286663
  40. 40

    Use of intravitreal dexamethasone implants in the treatment of diabetic macular edema: Expert recommendations using a Delphi approach.

    García Layana A, Adán A, Ascaso FJ, et al.

    European journal of ophthalmology 2020; (30(5)):1042-1052 doi:10.1177/1120672119861623.

    PMID: 31291782
  41. 41

    Imaging and Biomarkers in Diabetic Macular Edema and Diabetic Retinopathy.

    Kwan CC, Fawzi AA

    Current diabetes reports 2019; (19(10)):95 doi:10.1007/s11892-019-1226-2.

    PMID: 31473838
  42. 42

    IDF Diabetes Atlas: A review of studies utilising retinal photography on the global prevalence of diabetes related retinopathy between 2015 and 2018.

    Thomas RL, Halim S, Gurudas S, et al.

    Diabetes research and clinical practice 2019; (157()):107840 doi:10.1016/j.diabres.2019.107840.

    PMID: 31733978
  43. 43

    Oxidative Stress and Microvascular Alterations in Diabetic Retinopathy: Future Therapies.

    Rodríguez ML, Pérez S, Mena-Mollá S, et al.

    Oxidative medicine and cellular longevity 2019; (2019()):4940825 doi:10.1155/2019/4940825.

    PMID: 31814880
  44. 44

    Correlation between markers of renal function and sight-threatening diabetic retinopathy in type 2 diabetes: a longitudinal study in an Indian clinic population.

    Rajalakshmi R, Shanthi Rani CS, Venkatesan U, et al.

    BMJ open diabetes research & care 2020; (8(1)) doi:10.1136/bmjdrc-2020-001325.

    PMID: 32475840
  45. 45

    Novel imaging biomarkers in diabetic retinopathy and diabetic macular edema.

    Markan A, Agarwal A, Arora A, et al.

    Therapeutic advances in ophthalmology 2020; (12()):2515841420950513 doi:10.1177/2515841420950513.

    PMID: 32954207
  46. 46

    The Role of Inflammation in Diabetic Retinopathy.

    Forrester JV, Kuffova L, Delibegovic M

    Frontiers in immunology 2020; (11()):583687 doi:10.3389/fimmu.2020.583687.

    PMID: 33240272
  47. 47

    Anti-VEGF crunch syndrome in proliferative diabetic retinopathy: A review.

    Tan Y, Fukutomi A, Sun MT, et al.

    Survey of ophthalmology 2021; (66(6)):926-932 doi:10.1016/j.survophthal.2021.03.001.

    PMID: 33705807
  48. 48

    Optical Coherence Tomography-Based Prevalence of Diabetic Macular Edema and its Associated Risk Factors in Urban South India: A Population-Based Study.

    Pradhana D, Priya M N S, Surya J, et al.

    Ophthalmic epidemiology 2022; (29(2)):149-155 doi:10.1080/09286586.2021.1907846.

    PMID: 33856942
  49. 49

    Comparison of Central Macular Fluid Volume With Central Subfield Thickness in Patients With Diabetic Macular Edema Using Optical Coherence Tomography Angiography.

    You QS, Tsuboi K, Guo Y, et al.

    JAMA ophthalmology 2021; (139(7)):734-741 doi:10.1001/jamaophthalmol.2021.1275.

    PMID: 33983385
  50. 50

    Two Patients with Atypical Choroidal Detachment.

    Fong JW, Broyles HV, Atassi NY, et al.

    Case reports in ophthalmology 2021; (12(2)):315-319 doi:10.1159/000513220.

    PMID: 34054477
  51. 51

    LESSONS LEARNED FROM PACORES IN PROLIFERATIVE DIABETIC RETINOPATHY MANAGEMENT, DATA FROM LATIN AMERICA AND SPAIN: The Asbury Lecture 2020.

    Arevalo JF, Beatson B,

    Retina (Philadelphia, Pa.) 2022; (42(1)):4-10 doi:10.1097/IAE.0000000000003226.

    PMID: 34081638
  52. 52

    Management of Patients with Newly Diagnosed Diabetic Mellitus: Ophthalmologic Outcomes in Intensive versus Conventional Glycemic Control.

    Lam PY, Chow SC, Lam WC, et al.

    Clinical ophthalmology (Auckland, N.Z.) 2021; (15()):2767-2785 doi:10.2147/OPTH.S301317.

    PMID: 34234400
  53. 53

    Various models for diabetic retinopathy screening that can be applied to India.

    Rajalakshmi R, Prathiba V, Rani PK, Mohan V

    Indian journal of ophthalmology 2021; (69(11)):2951-2958 doi:10.4103/ijo.IJO_1145_21.

    PMID: 34708729
  54. 54

    OCT-based biomarkers for predicting treatment response in eyes with centre-involved diabetic macular oedema treated with anti-VEGF injections: a real-life retina clinic-based study.

    Szeto SK, Hui VWK, Tang FY, et al.

    The British journal of ophthalmology 2023; (107(4)):525-533 doi:10.1136/bjophthalmol-2021-319587.

    PMID: 34750100
  55. 55

    Early Worsening of Retinopathy in Type 1 and Type 2 Diabetes After Rapid Improvement in Glycaemic Control: A Systematic Review.

    Akil H, Burgess J, Nevitt S, et al.

    Diabetes therapy : research, treatment and education of diabetes and related disorders 2022; (13(1)):1-23 doi:10.1007/s13300-021-01190-z.

    PMID: 34928488
  56. 56

    Diabetic Retinopathy: An Overview of Treatments.

    Mounirou BAM, Adam ND, Yakoura AKH, et al.

    Indian journal of endocrinology and metabolism 2022; (26(2)):111-118 doi:10.4103/ijem.ijem_480_21.

    PMID: 35873941
  57. 57

    Systemic and Ocular Adverse Events with Intravitreal Anti-VEGF Therapy Used in the Treatment of Diabetic Retinopathy: a Review.

    Zehden JA, Mortensen XM, Reddy A, Zhang AY

    Current diabetes reports 2022; (22(10)):525-536 doi:10.1007/s11892-022-01491-y.

    PMID: 36053385
  58. 58

    YOSEMITE and RHINE: Phase 3 Randomized Clinical Trials of Faricimab for Diabetic Macular Edema: Study Design and Rationale.

    Eter N, Singh RP, Abreu F, et al.

    Ophthalmology science 2022; (2(1)):100111 doi:10.1016/j.xops.2021.100111.

    PMID: 36246184
  59. 59

    Laser Treatment Modalities for Diabetic Retinopathy.

    Pande GS, Tidake P

    Cureus 2022; (14(10)):e30024 doi:10.7759/cureus.30024.

    PMID: 36348830
  60. 60

    Epidemiology of Treated Diabetes Ocular Complications in France 2008-2018-The LANDSCAPE French Nationwide Study.

    Creuzot-Garcher C, Massin P, Srour M, et al.

    Pharmaceutics 2022; (14(11)) doi:10.3390/pharmaceutics14112330.

    PMID: 36365148
  61. 61

    Quantification of risk factors for diabetic retinopathy progression.

    Tarasewicz D, Conell C, Gilliam LK, Melles RB

    Acta diabetologica 2023; (60(3)):363-369 doi:10.1007/s00592-022-02007-6.

    PMID: 36527502
  62. 62

    Retinopathy prevalence, incidence and trajectories in type 2 diabetes: The Fremantle diabetes study phase II.

    Drinkwater JJ, Davis TME, Turner AW, Davis WA

    Diabetic medicine : a journal of the British Diabetic Association 2023; (40(4)):e15032 doi:10.1111/dme.15032.

    PMID: 36537852
  63. 63

    Social determinants of diabetic retinopathy and impact of sight-threatening diabetic retinopathy: A study from Pune, India.

    Kulkarni S, Patil V, Kashikar R, et al.

    Indian journal of ophthalmology 2023; (71(2)):358-362 doi:10.4103/ijo.IJO_1660_22.

    PMID: 36727320
  64. 64

    Safety and Efficacy of a Treat-and-Extend Regimen of Anti-Vascular Endothelial Growth Factor Agents for Diabetic Macular Edema or Macular Edema Secondary to Retinal Vein Occlusion: A Systematic Review and Meta-Analysis.

    Patil NS, Dhoot AS, Nichani PAH, et al.

    Ophthalmic surgery, lasers & imaging retina 2023; (54(3)):131-138 doi:10.3928/23258160-20230221-04.

    PMID: 36944072
  65. 65

    Blood pressure control for diabetic retinopathy.

    Do DV, Han G, Abariga SA, et al.

    The Cochrane database of systematic reviews 2023; (3()):CD006127 doi:10.1002/14651858.CD006127.pub3.

    PMID: 36975019
  66. 66

    Pathological Neurovascular Unit Mapping onto Multimodal Imaging in Diabetic Macular Edema.

    Murakami T, Ishihara K, Terada N, et al.

    Medicina (Kaunas, Lithuania) 2023; (59(5)) doi:10.3390/medicina59050896.

    PMID: 37241128
  67. 67

    Normative Data for Macular Thickness and Volume for Optical Coherence Tomography in a Diabetic Population without Maculopathies.

    Arruabarrena C, Rodríguez-Miguel A, de Aragón-Gómez F, et al.

    Journal of clinical medicine 2023; (12(16)) doi:10.3390/jcm12165232.

    PMID: 37629274
  68. 68

    Posterior vitreous detachment and retinal tear - a prospective study of community referrals.

    Nixon TRW, Davie RL, Snead MP

    Eye (London, England) 2024; (38(4)):786-791 doi:10.1038/s41433-023-02779-3.

    PMID: 37798362
  69. 69

    Programmatically Localizing Diabetic Retinopathy Features in 45-Degree Retinal Photographs Using Anatomical Colocation.

    Murphy TI, Douglass AG, van Wijngaarden P, Armitage JA

    Journal of clinical medicine 2024; (13(3)) doi:10.3390/jcm13030807.

    PMID: 38337501
  70. 70

    Sight-threatening diabetic retinopathy and its predictors among patients with diabetes visiting Adare General Hospital in Southern Ethiopia: a hospital-based cross-sectional study.

    Alemayehu HB, Tilahun MM, Abebe MG, Tegegn MT

    BMJ open 2024; (14(2)):e077552 doi:10.1136/bmjopen-2023-077552.

    PMID: 38387987
  71. 71

    Characterization of central-involved diabetic macular edema using OCT and OCTA.

    Reste-Ferreira D, Santos T, Marques IP, et al.

    European journal of ophthalmology 2025; (35(1)):290-297 doi:10.1177/11206721241248478.

    PMID: 38644796
  72. 72

    Diabetic Retinopathy-A Review.

    Pushparani DS, Varalakshmi J, Roobini K, et al.

    Current diabetes reviews 2025; (21(7)):43-55 doi:10.2174/0115733998296228240521151050.

    PMID: 38831577
  73. 73

    Multimodal imaging in diabetic retinopathy and macular edema: An update about biomarkers.

    Parravano M, Cennamo G, Di Antonio L, et al.

    Survey of ophthalmology 2024; (69(6)):893-904 doi:10.1016/j.survophthal.2024.06.006.

    PMID: 38942124
  74. 74

    Vitrectomy for cases of diabetic retinopathy.

    Shaikh N, Kumar V, Ramachandran A, et al.

    Indian journal of ophthalmology 2024; (72(12)):1704-1713 doi:10.4103/IJO.IJO_30_24.

    PMID: 39186637
  75. 75

    Early Versus Delayed Vitrectomy for Vitreous Hemorrhage Secondary to Proliferative Diabetic Retinopathy.

    Anguita R, Ferro Desideri L, Schwember P, et al.

    American journal of ophthalmology 2025; (270()):237-244 doi:10.1016/j.ajo.2024.10.019.

    PMID: 39471907
  76. 76

    A Deep Learning Segmentation Model for Detection of Active Proliferative Diabetic Retinopathy.

    Dinesen S, Schou MG, Hedegaard CV, et al.

    Ophthalmology and therapy 2025; (14(5)):1053-1063 doi:10.1007/s40123-025-01127-w.

    PMID: 40146482
  77. 77

    Gene Therapy in Diabetic Retinopathy and Diabetic Macular Edema: An Update.

    Odio-Herrera M, Orozco-Loaiza G, Wu L

    Journal of clinical medicine 2025; (14(9)) doi:10.3390/jcm14093205.

    PMID: 40364236
  78. 78

    Intravitreal faricimab for diabetic macular oedema and neovascular age-related macular degeneration: general considerations and practical recommendations by an expert panel of Italian retina specialists.

    Borrelli E, Boscia F, Lanzetta P, et al.

    Eye (London, England) 2025; (39(16)):3005-3014 doi:10.1038/s41433-025-03997-7.

    PMID: 40999227
  79. 79

    Adherence to the recommended diabetic retinopathy screening guidelines in pregnant women with pregestational diabetes: a cross-sectional survey study.

    Widyaputri F, Rogers SL, Nankervis AJ, et al.

    BMJ open 2025; (15(9)):e099917 doi:10.1136/bmjopen-2025-099917.

    PMID: 41027701
  80. 80

    Current and Emerging Pharmacologic Therapies for Diabetic Retinopathy.

    Clements JN, Mesawich J, Twisdale C

    Pharmacotherapy 2026; (46(3)):e70119 doi:10.1002/phar.70119.

    PMID: 41693076
  81. 81

    Do Vitreous Floaters Predict Retinal Detachment? Retrospective Cohort Study in Primary Care.

    van Zon B, Spoelder M, Peters HJ, et al.

    Annals of family medicine 2026; (24(2)):111-116 doi:10.1370/afm.240149.

    PMID: 41876118
  82. 82

    Diabetic retinopathy and kidney involvement in adults with type 2 diabetes in high-altitude Tibet: A cross-sectional subanalysis of the China National Diabetic Chronic Complications Study.

    Yang L, Zhang Z

    The Journal of international medical research 2026; (54(4)):3000605261437612 doi:10.1177/03000605261437612.

    PMID: 41954188
  83. 83

    Dysfunction of the Neurovascular Unit in Diabetic Retinopathy: Advances from Molecular Mechanisms to Targeted Interventions.

    Zhao C, Qin L, Zhang J, Wang X

    Stem cell reviews and reports 2026; doi:10.1007/s12015-026-11213-6.

    PMID: 42622757